Abstract
The article investigates the possibilities of import substitution in the Russian pharmaceutical market, the problems of the reaction of the Russian pharmaceutical industry to foreign sanctions foreign pharmaceutical firms. Recently, the Russian government’s policy is aimed at the development of its own economy, domestic production that entails new challenges and, at the same time, the prospects of development of the domestic pharmaceutical industry.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
